- Home
- NR vs THRD Comparison
NR vs THRD Comparison
Compare NR & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NR
- THRD
- Stock Information
- Founded
- NR 1932
- THRD 2019
- Country
- NR United States
- THRD United States
- Employees
- NR N/A
- THRD N/A
- Industry
- NR Metal Fabrications
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- NR Industrials
- THRD Health Care
- Exchange
- NR Nasdaq
- THRD Nasdaq
- Market Cap
- NR 629.7M
- THRD 513.2M
- IPO Year
- NR N/A
- THRD 2022
- Fundamental
- Price
- NR $7.78
- THRD $11.45
- Analyst Decision
- NR Strong Buy
- THRD Strong Buy
- Analyst Count
- NR 3
- THRD 3
- Target Price
- NR $11.00
- THRD $20.33
- AVG Volume (30 Days)
- NR 590.8K
- THRD 218.2K
- Earning Date
- NR 11-07-2024
- THRD 11-07-2024
- Dividend Yield
- NR N/A
- THRD N/A
- EPS Growth
- NR N/A
- THRD N/A
- EPS
- NR N/A
- THRD N/A
- Revenue
- NR $748,372,000.00
- THRD N/A
- Revenue This Year
- NR N/A
- THRD N/A
- Revenue Next Year
- NR N/A
- THRD N/A
- P/E Ratio
- NR N/A
- THRD N/A
- Revenue Growth
- NR 93.70
- THRD N/A
- 52 Week Low
- NR $5.61
- THRD $7.08
- 52 Week High
- NR $8.65
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- NR 64.61
- THRD 40.06
- Support Level
- NR $6.98
- THRD $10.10
- Resistance Level
- NR $7.27
- THRD $12.49
- Average True Range (ATR)
- NR 0.32
- THRD 1.30
- MACD
- NR 0.06
- THRD -0.32
- Stochastic Oscillator
- NR 87.71
- THRD 25.00
About NR Newpark Resources Inc.
Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.